# Hyogo Medical University

**Type:** Institutions  
**Canonical URL:** https://scholariq.org/institutions/hyogo-medical-university/

## Facts

| Field | Value |
| --- | --- |
| Avg h-index | 49.4 |
| Citations | 1,279,469 |
| City | Nishinomiya |
| Country | JP |
| Description | Hyogo Medical University is a research organisation in Nishinomiya, JP. OpenAlex records 16,795 works and 1,279,469 citations for it. 2,741 researchers list it as their most recent affiliation. |
| Homepage | https://www.hyo-med.ac.jp |
| OpenAlex ID | https://openalex.org/I137459256 |
| Researchers | 2,741 |
| ROR ID | https://ror.org/001yc7927 |
| Type | education |
| Wikidata ID | https://www.wikidata.org/wiki/Q5957059 |
| Works | 16,795 |

## University papers

Showing 12 of 116.

- [Gain-of-Function Mutations of c- <i>kit</i> in Human Gastrointestinal Stromal Tumors](https://scholariq.org/papers/gain-of-function-mutations-of-c-i-kit-i-in-human-gastrointestinal-stromal-tumors/)
- [The chemokine receptor CXCR4 is essential for vascularization of the gastrointestinal tract](https://scholariq.org/papers/the-chemokine-receptor-cxcr4-is-essential-for-vascularization-of-the/)
- [Predicting Successful Guidewire Crossing Through Chronic Total Occlusion of Native Coronary Lesions Within 30 Minutes](https://scholariq.org/papers/predicting-successful-guidewire-crossing-through-chronic-total-occlusion-of/)
- [Molecular cloning, expression, and gene localization of a fourth melanocortin receptor](https://scholariq.org/papers/molecular-cloning-expression-and-gene-localization-of-a-fourth-melanocortin/)
- [Endovascular Therapy for Acute Stroke with a Large Ischemic Region](https://scholariq.org/papers/endovascular-therapy-for-acute-stroke-with-a-large-ischemic-region/)
- [Effect of 1-Month Dual Antiplatelet Therapy Followed by Clopidogrel vs 12-Month Dual Antiplatelet Therapy on Cardiovascular and Bleeding Events in Patients Receiving PCI](https://scholariq.org/papers/effect-of-1-month-dual-antiplatelet-therapy-followed-by-clopidogrel-vs-12-month/)
- [Cardiac hypertrophy is inhibited by antagonism of ADAM12 processing of HB-EGF: Metalloproteinase inhibitors as a new therapy](https://scholariq.org/papers/cardiac-hypertrophy-is-inhibited-by-antagonism-of-adam12-processing-of-hb-egf/)
- [Molecular cloning of a novel melanocortin receptor.](https://scholariq.org/papers/molecular-cloning-of-a-novel-melanocortin-receptor/)
- [Lapatinib Plus Paclitaxel Versus Paclitaxel Alone in the Second-Line Treatment of <i>HER2</i>-Amplified Advanced Gastric Cancer in Asian Populations: TyTAN—A Randomized, Phase III Study](https://scholariq.org/papers/lapatinib-plus-paclitaxel-versus-paclitaxel-alone-in-the-second-line-treatment/)
- [Familial gastrointestinal stromal tumours with germline mutation of the KIT gene](https://scholariq.org/papers/familial-gastrointestinal-stromal-tumours-with-germline-mutation-of-the-kit-gene/)
- [Esophageal Disorders](https://scholariq.org/papers/esophageal-disorders/)
- [Phase III study comparing oxaliplatin plus S-1 with cisplatin plus S-1 in chemotherapy-naïve patients with advanced gastric cancer](https://scholariq.org/papers/phase-iii-study-comparing-oxaliplatin-plus-s-1-with-cisplatin-plus-s-1-in/)

## University researchers

- [Takeshi Morimoto](https://scholariq.org/researchers/takeshi-morimoto/)
- [Hiroto Miwa](https://scholariq.org/researchers/hiroto-miwa/)
- [Masanori Asakura](https://scholariq.org/researchers/masanori-asakura/)
- [Hirokazu Fukui](https://scholariq.org/researchers/hirokazu-fukui/)
- [Tadayuki Oshima](https://scholariq.org/researchers/tadayuki-oshima/)
- [Shinichiro Shinzaki](https://scholariq.org/researchers/shinichiro-shinzaki/)
- [Motoi Uchino](https://scholariq.org/researchers/motoi-uchino/)
- [Takaharu Oue](https://scholariq.org/researchers/takaharu-oue/)
- [Toshiyuki Sato](https://scholariq.org/researchers/toshiyuki-sato/)
- [Yuko Tazuke](https://scholariq.org/researchers/yuko-tazuke/)

## University top topics

Showing 8 of 25.

- [Gastric Cancer Management and Outcomes](https://scholariq.org/topics/gastric-cancer-management-and-outcomes/)
- [Inflammatory Bowel Disease](https://scholariq.org/topics/inflammatory-bowel-disease/)
- [Liver Disease Diagnosis and Treatment](https://scholariq.org/topics/liver-disease-diagnosis-and-treatment/)
- [Helicobacter pylori-related gastroenterology studies](https://scholariq.org/topics/helicobacter-pylori-related-gastroenterology-studies/)
- [Hepatocellular Carcinoma Treatment and Prognosis](https://scholariq.org/topics/hepatocellular-carcinoma-treatment-and-prognosis/)
- [Acute Ischemic Stroke Management](https://scholariq.org/topics/acute-ischemic-stroke-management/)
- [Immune Cell Function and Interaction](https://scholariq.org/topics/immune-cell-function-and-interaction/)
- [Cerebrovascular and Carotid Artery Diseases](https://scholariq.org/topics/cerebrovascular-and-carotid-artery-diseases/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.